Clinical trial
Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis
NCT00462020 · Children's Mercy Hospital Kansas City, Other · Completed
Key facts
| NCT number | NCT00462020 |
|---|---|
| Title | Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis |
| Official title | Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis |
| Lead sponsor | Children's Mercy Hospital Kansas City, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Perforated Appendicitis |
| Intervention type | Drug |
| Interventions | 5 days of IV antibiotics (ceftriaxone and metronidazole), Home with oral antibiotics when eating (ampicillin/clavulanic acid) |
| Enrollment | 102 |
| Start date | Mar 1, 2007 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Apr 18, 2007 |
| Last update posted | Feb 21, 2021 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: